For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ventricular (LV) diastolic function, according to a study published online Sept. 9 ...

Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with obesity and heart failure with preserved pump function, new research reveals. Weight ...

Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases and remains a major clinical and therapeutic challenge. Despite having preserved systolic ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.

Blood pressure consists of two numbers. Systolic pressure, the force exerted on blood vessels when the heart beats, is the upper number. Diastolic pressure, the force exerted when the heart is at rest ...

Diastolic dysfunction arises when the left ventricle fails to relax or fill normally during diastole, often despite a preserved ejection fraction. This impairment leads to elevated filling pressures, ...

Diastolic dysfunction increasingly is recognized as an important cause of congestive heart failure (CHF). In this study, Mayo Clinic researchers surveyed a random sample of 2042 adults (age, 45 or ...

A new review argues that heart failure with preserved ejection fraction in diabetes may represent a cardiac manifestation of ...